Company & Sponsor Intelligence

VA Office of Research and Development

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials29

Recruiting11

Completed17

Countries1

Therapeutic footprint

adhdalzheimersbipolar_disorderdepressionother_neurologyother_psychiatrypain_neuropathyparkinsonsptsdstrokesubstance_use

Indexed studies

NCT01156714Exercise and Cognitive Training in Parkinson's Disease
parkinsons · United StatesNA

NCT01676909Wellness Self-Management
other_psychiatry · United StatesNA

NCT00470418Development of NIC5-15 in the Treatment of Alzheimer's Disease
alzheimers · United StatesPHASE2

NCT03764033A Novel Posttraumatic Stress Disorder Treatment for Veterans With Moral Injury
ptsd · United StatesNA

NCT06596044Suicide Prevention After Community Care Discharge
other_psychiatry · United StatesNA

NCT02287038Atomoxetine in Veterans With Comorbid ADHD/PTSD
adhd · United StatesPHASE4

NCT04407767A Case Formulation Approach to Cognitive Processing Therapy
ptsd · United StatesNA

NCT05261282Mindful Hand Hygiene for Healthcare Workers
other_psychiatry · United StatesNA

NCT05400499Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
parkinsons · United StatesRECRUITING

NCT00946998Chronic Kidney Disease Antidepressant Sertraline Trial
depression · United StatesPHASE3

NCT01639469Telemedicine Intervention to Improve Physical Function
parkinsons · United StatesNA

NCT07362576Perinatal Peer Support for Veterans With Serious Mental Illness
other_neurology · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →